1. Chimeric Antigen Receptor-Engineered NK-92 Cells: An Off-the-Shelf Cellular Therapeutic for Targeted Elimination of Cancer Cells and Induction of Protective Antitumor Immunity
   Congcong Zhang et al, 2017, Front. Immunol. CrossRef
2. Genetic Manipulation of NK Cells for Cancer Immunotherapy: Techniques and Clinical Implications
   Mattias Carlsten et al, 2015, Front. Immunol. CrossRef
3. Role of Natural Killer Cells in HIV-Associated Malignancies
   Fabio E. Leal et al, 2017, Front. Immunol. CrossRef
4. hIL-15-gene modified human natural killer cells (NKL-IL15) exhibit anti-human leukemia functions
   Wen Jiang et al, 2018, J Cancer Res Clin Oncol CrossRef
5. Human Interleukin-15 Improves Engraftment of Human T Cells in NOD-SCID Mice
   Anyuan Sun et al, 2006, CVI CrossRef
6. The Advances and Challenges of NK Cell-Based Cancer Immunotherapy
   Synat Kang et al, 2021, Current Oncology CrossRef
7. Prolonged Culture of Vaccine-Primed Lymphocytes Results in Decreased Antitumor Killing and Change in Cytokine Secretion
   Jeffrey J. Sussman et al, 2004 CrossRef